Wuhan Total Current Liabilities from 2010 to 2024

300871 Stock   12.71  0.22  1.76%   
Wuhan Hvsen's Total Current Liabilities is increasing over the years with slightly volatile fluctuation. Total Current Liabilities is expected to dwindle to about 410.7 M. Total Current Liabilities is the total amount of liabilities that Wuhan Hvsen Biotechnology is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2010-12-31
Previous Quarter
781.1 M
Current Value
410.7 M
Quarterly Volatility
250.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Wuhan Hvsen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wuhan Hvsen's main balance sheet or income statement drivers, such as Interest Expense of 29.6 M, Other Operating Expenses of 5.6 M or Net Income Applicable To Common Shares of 96.4 M, as well as many indicators such as . Wuhan financial statements analysis is a perfect complement when working with Wuhan Hvsen Valuation or Volatility modules.
  
This module can also supplement various Wuhan Hvsen Technical models . Check out the analysis of Wuhan Hvsen Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Wuhan Stock

Wuhan Hvsen financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Hvsen security.